Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Universe Pharmaceuticals Incorporation (UPC)
:UPC
Holding UPC?
Track your performance easily
UPC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.48 - $64.80
Previous CloseN/A
Volume250.22K
Average Volume (3M)4.51M
Market Cap
$1.10M
Enterprise Value$3.10M
Total Cash (Recent Filing)$6.19M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.04
Next Earnings
Feb 04, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.10
Shares Outstanding2,103,184
10 Day Avg. Volume865,328
30 Day Avg. Volume4,514,026
Standard Deviation0.38
R-Squared0.03
Alpha-0.06
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.03
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap2.83
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.30
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Universe Pharmaceuticals News
PremiumCompany Announcements
Universe Pharmaceuticals Files Registration for 37.5 Million Shares
PremiumMarket News
3 Penny Stocks to Watch Now, 12/10/24
PremiumCompany Announcements
Universe Pharmaceuticals Announces Share Consolidation Plan
PremiumCompany Announcements
Universe Pharmaceuticals Faces Nasdaq Compliance ChallengeOwnership Overview
―
Insiders
0.07%
Mutual Funds
― Other Institutional Investors
99.93% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
UPC FAQ
What was Universe Pharmaceuticals Incorporation’s price range in the past 12 months?
Universe Pharmaceuticals Incorporation lowest stock price was $0.48 and its highest was $64.80 in the past 12 months.
What is Universe Pharmaceuticals Incorporation’s market cap?
Universe Pharmaceuticals Incorporation’s market cap is $1.10M.
When is Universe Pharmaceuticals Incorporation’s upcoming earnings report date?
Universe Pharmaceuticals Incorporation’s upcoming earnings report date is Feb 04, 2025 which is in 13 days.
How were Universe Pharmaceuticals Incorporation’s earnings last quarter?
Universe Pharmaceuticals Incorporation released its earnings results on Sep 20, 2024. The company reported -$3.593 earnings per share for the quarter, missing the consensus estimate of N/A by -$3.593.
Is Universe Pharmaceuticals Incorporation overvalued?
According to Wall Street analysts Universe Pharmaceuticals Incorporation’s price is currently Overvalued.
Does Universe Pharmaceuticals Incorporation pay dividends?
Universe Pharmaceuticals Incorporation does not currently pay dividends.
What is Universe Pharmaceuticals Incorporation’s EPS estimate?
Universe Pharmaceuticals Incorporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Universe Pharmaceuticals Incorporation have?
Universe Pharmaceuticals Incorporation has 2,103,184 shares outstanding.
What happened to Universe Pharmaceuticals Incorporation’s price movement after its last earnings report?
Universe Pharmaceuticals Incorporation reported an EPS of -$3.593 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -14.059%.
Which hedge fund is a major shareholder of Universe Pharmaceuticals Incorporation?
Currently, no hedge funds are holding shares in UPC
---
Company Description
Universe Pharmaceuticals Incorporation
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the aging process and to promote their general well-being. The company also sells biomedical drugs medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
---
Technical Analysis
SELLAS Life Sciences Group
―
Can-Fite BioPharma
―
CASI Pharmaceuticals
―
GlaxoSmithKline
―
AbbVie
―
---